Wang, S., Wang, X., Liu, S., Zhang, S., Wei, X., Song, Y., & Yin, Q. (2020). The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia. Onco Targets Ther.

Wang, Shan, Xiaojiao Wang, Sha Liu, Shengnan Zhang, Xudong Wei, Yongping Song, and Qingsong Yin. "The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia." Onco Targets Ther 2020.

Wang, Shan, et al. "The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia." Onco Targets Ther 2020.